Contact Us

News

Experience the Extraordinary!

Antharis
3/20/2024

Unlocking Potential: Dr. Pinaud's Visionary Leadership Drives Innovation in Antharis Therapeutics and the Biotech Industry

Dr. Pinaud's leadership philosophy inspires a culture of innovation and patient-centricity at Antharis Therapeutics, fostering a dynamic ecosystem for the creation of novel, transformative healthcare solutions.

Read More
2/15/2024

The Top Emerging Biopharmaceutical Company Developing New Treatments for Unmet Medical Needs: Antharis Therapeutics

Antharis employs a sophisticated, multi-disciplinary scientific program encompassing immunology, cellular biology, and molecular biology to drive therapeutic advancements.

Read More
2/15/2024

Antharis Therapeutics: Immuno-Oncological Approach to Cancer Treatment

Antharis Therapeutics, a biopharmaceutical company, stands at the forefront of this shift, where it develops monoclonal antibodies (mAbs) to treat cancer.

Read More
2/15/2024

Driving Transformative Impact in the Biopharmaceutical Industry

From developing transformative therapies for patients suffering from unmet medical needs to pioneering cutting-edge technologies that will improve patient outcomes and ultimately save lives, business leaders and entrepreneurs are raising the standards of healthcare through technology and innovation.

Read More
12/14/2023

Antharis Therapeutics Acquires Cassyni Biopharma and Their Portfolio of Assets

SAN DIEGO—Antharis Therapeutics Inc., a biopharmaceutical company developing a leading portfolio of oncology and neurology related immunotherapeutics, today announced the completion and integration of their acquisition of Cassyni Biopharma.

Read More
12/14/2023

Antharis Therapeutics Acquires Galileo Biotech

SAN DIEGO—Antharis Therapeutics, a four-year-old biopharmaceutical company developing a leading portfolio of oncology- and neurology-related immunotherapeutics, today announced the completion of its acquisition of Galileo Biotech (São Paulo, Brazil). This exciting acquisition includes X additional employees and X square feet of state-of-the-art GMP-certified laboratory space.

Read More
760-481-7609
1396 Poinsettia Ave, Vista, CA 92081, United States
Linkedin
contact@antharistherapeutics.com

PRIVACY POLICY & TERMS OF USE

Copyright © 2024 Antharis Therapeutics develops cutting-edge therapies that harness the immune system towards cures for a number of unmet medical needs, including a variety of cancers.